Speaker Faculty

Umberto Malapelle

Assistant Professor of Anatomic Pathology, Department of Public Health

University of Naples Frederico II

Leeona Galligan

Vice President of UK Operations

Almac Diagnostic Services

Partha Das

Medical Director, CDx & Biomarker Strategy

Amgen

Darren Hodgson

Global Project Leader and Site Head Translational Medicine

AstraZeneca Oncology

Trevor Pitcher

Director, Medical Affairs and Medical Information

Biodesix

Lauren Leiman

Executive Director

BloodPAC

Jonathan Badan

Senior Director, Pharmacodiagnostics & Precision Medicine

Bristol-Myers Squibb

Ajay Goel

Professor and Chair, Department of Molecular Diagnostics and Experimental Therapeutics

City of Hope

Zheng Feng

Director / Head of Molecular Biomarker & Genomics, Global Clinical Biomarkers & Companion Diagnostics

EMD Serono

Joseph Schonhoft

Manager, Translational Research

Epic Sciences

Daniel Enderle

Scientific Director, CDx

Exosome Diagnostics

Brent Witgen

Site Head and Director of Laboratory Operations

Foundation Medicine

Priti Hedge

Chief Scientific Officer

Foundation Medicine

Jami DeBrando- Palumbo

Senior Vice President

Foundation Medicine

Chris Karlovich

Associate Director, Molecular Characterization Laboratory

Frederick National Laboratory for Cancer

Mark Stewart

Vice President, Science Policy

Friends of Cancer Research

Guneet Walia

Platform Strategy Leader

Genentech

Neeraj Adya

Head of Diagnostics

Genmab

Daniel Simon

Senior Vice President, BioPharma Business Development

Guardant Health

Kathryn Lang

Vice President, Outcomes and Evidence

Guardant Health

Patrick Eimerman

Director of Business Development

Guardant Health

Mike Makrigiorgos

Professor and Director, Medical Physics & Biophysics Division

Harvard Medical School

Matt Nelson

Senior Director, Companion Diagnostic Partnering

Illumina

Tim Forshew

Head of Science & Innovation and Co- Founder

Inivata

Stefan Scherer

Medical Advisor

Inivata

Robert McCormack

Independent

Dave Hoon

Director, Center of Translational Molecular Medicine, Professor of Genomic Sequencing Center

John Wayne Cancer Institute

Mark Nunes

Division Chief, Medical Genetics

Kaiser Permanente LAMC

Taylor Jensen

Strategic Director, Research and Development

Labcorp

Carol Pena

Executive Director, Translational Molecular Biomarkers and Diagnostics

Merck

Howard I. Scher, MD, FASCO

Head, Biomarker Development Program Attending Physician Department of Medicine

Memorial Sloan Kettering Cancer Center

Gideon Blumenthal

Vice President of Global Regulatory Affairs for Oncology

Merck

Andy Hadd

Director of Regulatory Affairs

Natera

Angel Rodriguez

Oncology Medical Director

Natera

Olga Alexeeva

Business Development Strategy

Natera

Gary Kelloff

Special Advisor

National Cancer Institute

Shari Brown

Director of Molecular Pathology Services

NeoGenomics Laboratories

Jonathan Beer

Director of Disruptive Technologies

Novartis

Shubha Chaudhari

Head of Digital Transformation

Novartis

Jean-Francois Martini

Senior Director, Translational Oncology Lead, Global Product Development

Pfizer

Marielena Mata

Director & Diagnostic Lead

Pfizer

Ronny Kellner

Senior Scientist, Research & Development, dPCR Assay Development

Qiagen

Catherine Alix-Panabières

Associate Professor & Principal Investigator

The University of Montpellier

Elizabeth Attias

Chief Strategy and Development Officer

Sermonix Pharmaceuticals

Javier Perez Director

Precision Medicine, Companion Diagnostics

Regeneron Pharmaceuticals

Joshua Xu

Branch Chief

U.S Food & Drug Administration

Kim Blackwell

Chief Medical Officer

Tempus Labs

Luca Quagliata

Vice President, Global Head of Medical Affairs

Thermo Fisher Scientific

Ana Slipicevic

Translational Research Director

Oncopeptides AB

Debra Rasmussen

Global Regulatory Affairs Diagnostic / Digital Leader

Janssen

Kelli Bramlett

Director R&D

Thermo Fisher Scientific

Laura Sun

Director, Translational Medicine & Product Development Team Lead

Harpoon Therapeutics

Shirin K. Ford

Head, Clinical Biomarkers & Companion Diagnostics, Global Oncology R&D

Daiichi Sankyo